These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22977003)

  • 1. Remember what I told you about therapeutic arteriogenesis, 11 years ago?
    Post MJ
    Cardiovasc Res; 2012 Nov; 96(2):152-3; discussion 154-6. PubMed ID: 22977003
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course of arteriogenesis following femoral artery occlusion in the rabbit.
    Hoefer IE; van Royen N; Buschmann IR; Piek JJ; Schaper W
    Cardiovasc Res; 2001 Feb; 49(3):609-17. PubMed ID: 11166274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriogenesis: mechanisms and modulation of collateral artery development.
    Van Royen N; Piek JJ; Schaper W; Bode C; Buschmann I
    J Nucl Cardiol; 2001; 8(6):687-93. PubMed ID: 11725265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models].
    Erdo F; Buschmann IR
    Orv Hetil; 2007 Apr; 148(14):633-42. PubMed ID: 17403636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.
    Grundmann S; van Royen N; Pasterkamp G; Gonzalez N; Tijsma EJ; Piek JJ; Hoefer IE
    J Am Coll Cardiol; 2007 Jul; 50(4):351-8. PubMed ID: 17659203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
    Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
    Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiogenic growth factors in arteriogenesis.
    Schierling W; Troidl K; Troidl C; Schmitz-Rixen T; Schaper W; Eitenmüller IK
    J Vasc Res; 2009; 46(4):365-74. PubMed ID: 19142016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic site selection is important for the successful development of collateral vessels.
    Nishiyama A; Koyama H; Miyata T; Watanabe T
    J Vasc Surg; 2015 Jul; 62(1):190-9. PubMed ID: 24630870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arteriogenesis versus angiogenesis in peripheral artery disease.
    Troidl K; Schaper W
    Diabetes Metab Res Rev; 2012 Feb; 28 Suppl 1():27-9. PubMed ID: 22271719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis].
    Schirmer SH; van Royen N; Laufs U; Böhm M
    Dtsch Med Wochenschr; 2009 Feb; 134(7):302-6. PubMed ID: 19197812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced arteriogenesis in mice overexpressing erythropoietin.
    Scholz D; Schaper W
    Cell Tissue Res; 2006 Jun; 324(3):395-401. PubMed ID: 16485134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic manipulation of the collateral circulation--future directions.
    van Royen N; Piek JJ
    Coron Artery Dis; 2004 Nov; 15(7):399-403. PubMed ID: 15492588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis.
    Schirmer SH; Buschmann IR; Jost MM; Hoefer IE; Grundmann S; Andert JP; Ulusans S; Bode C; Piek JJ; van Royen N
    Cardiovasc Res; 2004 Nov; 64(2):356-64. PubMed ID: 15485696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The range of adaptation by collateral vessels after femoral artery occlusion.
    Eitenmüller I; Volger O; Kluge A; Troidl K; Barancik M; Cai WJ; Heil M; Pipp F; Fischer S; Horrevoets AJ; Schmitz-Rixen T; Schaper W
    Circ Res; 2006 Sep; 99(6):656-62. PubMed ID: 16931799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiogenesis and arteriogenesis; the long road from concept to clinical application].
    Voskuil M; van Royen N; Hoefer I; Buschmann I; Schaper W; Piek JJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):670-5. PubMed ID: 11530702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion.
    Ito WD; Arras M; Winkler B; Scholz D; Schaper J; Schaper W
    Circ Res; 1997 Jun; 80(6):829-37. PubMed ID: 9168785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into mechanisms behind arteriogenesis: what does the future hold?
    van Oostrom MC; van Oostrom O; Quax PH; Verhaar MC; Hoefer IE
    J Leukoc Biol; 2008 Dec; 84(6):1379-91. PubMed ID: 18678607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells and CD4+ T-cells modulate collateral artery development.
    van Weel V; Toes RE; Seghers L; Deckers MM; de Vries MR; Eilers PH; Sipkens J; Schepers A; Eefting D; van Hinsbergh VW; van Bockel JH; Quax PH
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2310-8. PubMed ID: 17717295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusion.
    Vajanto I; Korpisalo P; Karjalainen J; Hakala T; Mäkinen K; Ylä-Herttuala S
    Eur J Clin Invest; 2009 Dec; 39(12):1048-54. PubMed ID: 19807785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes.
    Hoefer IE; Grundmann S; van Royen N; Voskuil M; Schirmer SH; Ulusans S; Bode C; Buschmann IR; Piek JJ
    Atherosclerosis; 2005 Aug; 181(2):285-93. PubMed ID: 16039282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.